Literature DB >> 24554664

Inhibition of Kaposi's sarcoma-associated herpesvirus lytic replication by HIV-1 Nef and cellular microRNA hsa-miR-1258.

Qin Yan1, Xinting Ma, Chenyou Shen, Xu Cao, Ninghan Feng, Di Qin, Yi Zeng, Jianzhong Zhu, Shou-Jiang Gao, Chun Lu.   

Abstract

UNLABELLED: Kaposi's sarcoma-associated herpesvirus (KSHV) is causally linked to several AIDS-related malignancies, including Kaposi's sarcoma (KS), primary effusion lymphoma (PEL), and multicentric Castleman's disease. The interaction of human immunodeficiency virus type 1 (HIV-1) and KSHV has a central role in promoting the aggressive manifestations of AIDS-KS. We have previously shown that negative factor (Nef), a secreted HIV-1 protein, synergizes with KSHV viral interleukin-6 (vIL-6) to promote angiogenesis and tumorigenesis by activating the AKT pathway (X. Zhu, et al., Oncogene, 22 April 2013, http://dx.doi.org/10.1038/onc.2013.136). Here, we further demonstrated the role of soluble and ectopic Nef in the regulation of KSHV latency. We found that both soluble Nef protein and ectopic expression of Nef by transfection suppressed the expression of KSHV viral lytic mRNA transcripts and proteins and the production of infectious viral particles. MicroRNA (miRNA) microarray analysis identified a number of Nef-regulated miRNAs. Bioinformatics and luciferase reporter analyses showed that one of the Nef-upregulated miRNAs, cellular miRNA 1258 (hsa-miR-1258), directly targeted a seed sequence in the 3' untranslated region (UTR) of the mRNA encoding the major lytic switch protein (RTA), which controls KSHV reactivation from latency. Ectopic expression of hsa-miR-1258 impaired RTA synthesis and enhanced Nef-mediated inhibition of KSHV replication, whereas repression of hsa-miR-1258 has the opposite effect. Mutation of the seed sequence in the RTA 3'UTR abolished downregulation of RTA by hsa-miR-1258. Collectively, these novel findings demonstrate that, by regulating cellular miRNA, Nef may inhibit KSHV replication to promote viral latency and contribute to the pathogenesis of AIDS-related malignancies. IMPORTANCE: This study found that Nef, a secreted HIV-1 protein, suppressed KSHV lytic replication to promote KSHV latency. Mechanistic studies indicated that a Nef-upregulated cellular miRNA, hsa-miR-1258, inhibits KSHV replication by directly targeting a seed sequence in the KSHV RTA 3'UTR. These results illustrate that, in addition to viral miRNAs, cellular miRNAs also play an important role in regulating the life cycle of KSHV. Overall, this is the first study to report the involvement of Nef in KSHV latency, implying its likely important role in the pathogenesis of AIDS-related malignancies.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24554664      PMCID: PMC3993842          DOI: 10.1128/JVI.00025-14

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  92 in total

1.  Reciprocal regulatory interaction between human herpesvirus 8 and human immunodeficiency virus type 1.

Authors:  L M Huang; M F Chao; M Y Chen; Y P Chiang; C Y Chuang; C Y Lee
Journal:  J Biol Chem       Date:  2001-01-11       Impact factor: 5.157

2.  The conserved core of human immunodeficiency virus type 1 Nef is essential for association with Lck and for enhanced viral replication in T-lymphocytes.

Authors:  H Cheng; J P Hoxie; W P Parks
Journal:  Virology       Date:  1999-11-10       Impact factor: 3.616

3.  Complete remission of AIDS-related Kaposi's sarcoma associated with undetectable human herpesvirus-8 sequences during anti-HIV protease therapy.

Authors:  L Blum; C Pellet; F Agbalika; G Blanchard; P Morel; F Calvo; C Lebbé
Journal:  AIDS       Date:  1997-11       Impact factor: 4.177

4.  Human immunodeficiency virus 1 Nef suppresses CD40-dependent immunoglobulin class switching in bystander B cells.

Authors:  Xugang Qiao; Bing He; April Chiu; Daniel M Knowles; Amy Chadburn; Andrea Cerutti
Journal:  Nat Immunol       Date:  2006-01-22       Impact factor: 25.606

5.  HIV Type 1 Nef is released from infected cells in CD45(+) microvesicles and is present in the plasma of HIV-infected individuals.

Authors:  A D Raymond; T C Campbell-Sims; M Khan; M Lang; M B Huang; V C Bond; M D Powell
Journal:  AIDS Res Hum Retroviruses       Date:  2010-10-21       Impact factor: 2.205

6.  Regulation of tumor necrosis factor-like weak inducer of apoptosis receptor protein (TWEAKR) expression by Kaposi's sarcoma-associated herpesvirus microRNA prevents TWEAK-induced apoptosis and inflammatory cytokine expression.

Authors:  Johanna R Abend; Thomas Uldrick; Joseph M Ziegelbauer
Journal:  J Virol       Date:  2010-09-15       Impact factor: 5.103

7.  The human immunodeficiency virus type 1 Nef protein binds the Src-related tyrosine kinase Lck SH2 domain through a novel phosphotyrosine independent mechanism.

Authors:  H Dutartre; M Harris; D Olive; Y Collette
Journal:  Virology       Date:  1998-08-01       Impact factor: 3.616

8.  Release, uptake, and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation.

Authors:  B Ensoli; L Buonaguro; G Barillari; V Fiorelli; R Gendelman; R A Morgan; P Wingfield; R C Gallo
Journal:  J Virol       Date:  1993-01       Impact factor: 5.103

9.  Kaposi's sarcoma herpesvirus microRNAs target caspase 3 and regulate apoptosis.

Authors:  Guillaume Suffert; Georg Malterer; Jean Hausser; Johanna Viiliäinen; Aurélie Fender; Maud Contrant; Tomi Ivacevic; Vladimir Benes; Frédéric Gros; Olivier Voinnet; Mihaela Zavolan; Päivi M Ojala; Juergen G Haas; Sébastien Pfeffer
Journal:  PLoS Pathog       Date:  2011-12-08       Impact factor: 6.823

10.  Activation of PI3K/AKT and ERK MAPK signal pathways is required for the induction of lytic cycle replication of Kaposi's sarcoma-associated herpesvirus by herpes simplex virus type 1.

Authors:  Di Qin; Ninghan Feng; Weifei Fan; Xinting Ma; Qin Yan; Zhigang Lv; Yi Zeng; Jianzhong Zhu; Chun Lu
Journal:  BMC Microbiol       Date:  2011-10-27       Impact factor: 3.605

View more
  22 in total

1.  Suppression of the SAP18/HDAC1 complex by targeting TRIM56 and Nanog is essential for oncogenic viral FLICE-inhibitory protein-induced acetylation of p65/RelA, NF-κB activation, and promotion of cell invasion and angiogenesis.

Authors:  Xiangya Ding; Jingyun Xu; Cong Wang; Qi Feng; Qingxia Wang; Yue Yang; Hongmei Lu; Fei Wang; Kaixiang Zhu; Wan Li; Qin Yan; Shou-Jiang Gao; Chun Lu
Journal:  Cell Death Differ       Date:  2019-01-22       Impact factor: 15.828

2.  MicroRNA miR-BART20-5p stabilizes Epstein-Barr virus latency by directly targeting BZLF1 and BRLF1.

Authors:  Yu-Jin Jung; Hoyun Choi; Hyoji Kim; Suk Kyeong Lee
Journal:  J Virol       Date:  2014-06-04       Impact factor: 5.103

3.  Upregulation of MicroRNA 711 Mediates HIV-1 Vpr Promotion of Kaposi's Sarcoma-Associated Herpesvirus Latency and Induction of Pro-proliferation and Pro-survival Cytokines by Targeting the Notch/NF-κB-Signaling Axis.

Authors:  Qin Yan; Runran Zhao; Chenyou Shen; Fei Wang; Wan Li; Shou-Jiang Gao; Chun Lu
Journal:  J Virol       Date:  2018-08-29       Impact factor: 5.103

Review 4.  Does persistent HIV replication explain continued lymphoma incidence in the era of effective antiretroviral therapy?

Authors:  Jennifer Totonchy; Ethel Cesarman
Journal:  Curr Opin Virol       Date:  2016-09-23       Impact factor: 7.090

5.  HIV-1 Vpr Inhibits Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication by Inducing MicroRNA miR-942-5p and Activating NF-κB Signaling.

Authors:  Qin Yan; Chenyou Shen; Jie Qin; Wan Li; Minmin Hu; Hongmei Lu; Di Qin; Jianzhong Zhu; Shou-Jiang Gao; Chun Lu
Journal:  J Virol       Date:  2016-09-12       Impact factor: 5.103

Review 6.  Viral miRNA targeting of bicistronic and polycistronic transcripts.

Authors:  Ying Zhu; Yufei Huang; Jae U Jung; Chun Lu; Shou-Jiang Gao
Journal:  Curr Opin Virol       Date:  2014-05-10       Impact factor: 7.090

Review 7.  How do viruses trick B cells into becoming lymphomas?

Authors:  Ethel Cesarman
Journal:  Curr Opin Hematol       Date:  2014-07       Impact factor: 3.284

Review 8.  Role of host microRNAs in Kaposi's sarcoma-associated herpesvirus pathogenesis.

Authors:  Zhiqiang Qin; Francesca Peruzzi; Krzysztof Reiss; Lu Dai
Journal:  Viruses       Date:  2014-11-21       Impact factor: 5.048

9.  A KSHV microRNA Directly Targets G Protein-Coupled Receptor Kinase 2 to Promote the Migration and Invasion of Endothelial Cells by Inducing CXCR2 and Activating AKT Signaling.

Authors:  Minmin Hu; Cong Wang; Wan Li; Weiping Lu; Zhiqiang Bai; Di Qin; Qin Yan; Jianzhong Zhu; Brian J Krueger; Rolf Renne; Shou-Jiang Gao; Chun Lu
Journal:  PLoS Pathog       Date:  2015-09-24       Impact factor: 6.823

10.  MiRNA-891a-5p mediates HIV-1 Tat and KSHV Orf-K1 synergistic induction of angiogenesis by activating NF-κB signaling.

Authors:  Shuihong Yao; Minmin Hu; Tingting Hao; Wan Li; Xue Xue; Min Xue; Xiaofei Zhu; Feng Zhou; Di Qin; Qin Yan; Jianzhong Zhu; Shou-Jiang Gao; Chun Lu
Journal:  Nucleic Acids Res       Date:  2015-10-07       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.